Orum Therapeutics, Inc. (KOSDAQ:475830)
66,800
+3,900 (6.20%)
May 20, 2026, 3:30 PM KST
224.27% (1Y)
| Market Cap | 1.44T +150.6% |
| Revenue (ttm) | 23.56M -99.9% |
| Net Income | -41.97B |
| EPS | -2,017.00 |
| Shares Out | 21.51M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 237,578 |
| Average Volume | 200,247 |
| Open | 61,000 |
| Previous Close | 62,900 |
| Day's Range | 61,000 - 67,900 |
| 52-Week Range | 15,950 - 146,600 |
| Beta | n/a |
| RSI | 34.29 |
| Earnings Date | Apr 3, 2026 |